Psychiatry Research: Neuroimaging
Volume 174, Issue 2 , Pages 121-129 , 30 November 2009

The effect of clozapine on regional cerebral blood flow and brain metabolite ratios in schizophrenia: Relationship with treatment response

  • Aygun Ertugrul

      Affiliations

    • Hacettepe University, Faculty of Medicine, Department of Psychiatry, Ankara, Turkey
    • Corresponding Author InformationCorresponding author. Hacettepe University, Faculty of Medicine, Department of Psychiatry, Ankara 06100, Turkey. Tel.: +90 312 305 18 73; fax: +90 312 310 19 38.
    • ,
  • Bilge Volkan-Salanci

      Affiliations

    • Hacettepe University, Faculty of Medicine, Department of Nuclear Medicine, Ankara, Turkey
    • ,
  • Koray Basar

      Affiliations

    • Hacettepe University, Faculty of Medicine, Department of Psychiatry, Ankara, Turkey
    • ,
  • Kader Karli Oguz

      Affiliations

    • Hacettepe University, Faculty of Medicine, Department of Radiology, Ankara, Turkey
    • ,
  • Basaran Demir

      Affiliations

    • Hacettepe University, Faculty of Medicine, Department of Psychiatry, Ankara, Turkey
    • ,
  • Eser Lay Ergun

      Affiliations

    • Hacettepe University, Faculty of Medicine, Department of Nuclear Medicine, Ankara, Turkey
    • ,
  • Senem Senturk

      Affiliations

    • Hacettepe University, Faculty of Medicine, Department of Radiology, Ankara, Turkey
    • ,
  • Belkis Erbas

      Affiliations

    • Hacettepe University, Faculty of Medicine, Department of Nuclear Medicine, Ankara, Turkey
    • ,
  • Aysenur Cila

      Affiliations

    • Hacettepe University, Faculty of Medicine, Department of Radiology, Ankara, Turkey
    • ,
  • Berna Ulug

      Affiliations

    • Hacettepe University, Faculty of Medicine, Department of Psychiatry, Ankara, Turkey

Received 13 October 2007 ,Revised 13 January 2009 ,Accepted 15 April 2009.

References 

  1. Andreasen, N.C., Rezai, K., Alliger, R., Swayze, V.W. 2nd, Flaum, M., Kirchner, P., Cohen, G., O'Leary, D.S., 1992. Hypofrontality in neuroleptic naive patients and in patients with chronic schizophrenia. Archives of General Psychiatry 49, 943–958.
  2. Anil AE, Kivircik BB, Batur S, Kabakci E, Kitis A, Guven E, et al. The Turkish version of the Auditory Consonant Trigram Test as a measure of working memory: a normative study. Clinical Neuropsychologist. 2003;17:159–169
  3. Bai O, Chlan-Fourney J, Bowen R, Keegan D, Li XM. Expression of BDNF m RNA in rat hippocampus after treatment with antipsychotic drugs. Journal of Neuroscience Research. 2003;71:127–131
  4. Baslow MH. Functions of N-acetyl-L-aspartate and N-acetyl-L-aspartylglutamate in the vertebrate brain: role in glial cell-specific signaling. Journal of Neurochemistry. 2000;75:453–459
  5. Benton AL, Hamsher K. Multilingual Aphasia Examination: Manual of Instructions. IOWA City: AJA Associates; 1978;
  6. Bertolino A, Callicott JH, Elman I, Mattay VS, Tedeschi G, Frank JA, et al. Regionally specific neuronal pathology in untreated patients with schizophrenia: a proton magnetic resonance spectroscopic imaging study. Biological Psychiatry. 1998;43:641–648
  7. Bertolino A, Callicott JH, Mattay VS, Weidenhammer KM, Rakow R, Egan MF, et al. The effect of treatment with antipsychotic drugs on brain N-acetylaspartate measures in patients with schizophrenia. Biological Psychiatry. 2001;49:39–46
  8. Brambilla P, Stanley JA, Nicoletti MA, Sassi RB, Mallinger AG, Frank E, et al. 1H Magnetic resonance spectroscopy study of dorsolateral prefrontal cortex in unipolar mood disorder patients. Psychiatry Research. 2005;138:131–139
  9. Braus DF, Ende G, Weber-Fahr W, Demirakca T, Henn FA. Favorable effect on neuronal viability in the anterior cingulate gyrus due to long-term treatment with atypical antipsychotics: an MRSI study. Pharmacopsychiatry. 2001;34:251–253
  10. Braus DF, Ende G, Weber-Fahre W, Demirakca T, Tost H, Henn FA. Functioning and neuronal viability of the anterior cingulate neurons following antipsychotic treatment: MR-spectroscopic imaging in chronic schizophrenia. European Neuropsychopharmacology. 2002;12:145–152
  11. Buchsbaum MS, Hazlett EA, Haznedar MM, Spiegel-Cohen J, Wei TC. Visualizing fronto–striatal circuitry and neuroleptic effects in schizophrenia. Acta Psychiatrica Scandinavica Supplement. 1999;395:129–137
  12. Bustillo JR, Lauriello J, Rowland LM, Jung RE, Petropoulos H, Hart BL, et al. Effects of chronic haloperidol and clozapine treatments on frontal and caudate neurochemistry in schizophrenia. Psychiatry Research. 2001;107:135–149
  13. Bustillo JR, Lauriello J, Rowland LM, Thomson LM, Petropoulos H, Hammond R, et al. Longitudinal follow-up of neurochemical changes during the first year of antipsychotic treatment in schizophrenia patients with minimal previous medication exposure. Schizophrenia Research. 2002;58:313–321
  14. Bustillo J, Wolff C, Myers-y-Gutierrez A, Dettmer TS, Cooper TB, Allan A, et al. Treatment of rats with antipsychotic drugs: lack of an effect on brain N-acetyl aspartate levels. Schizophrenia Research. 2004;66:31–39
  15. Cecil KM, Lenkinski RE, Gur RE, Gur RC. Proton magnetic resonance spectroscopy in the frontal and temporal lobes of neuroleptic naive patients with schizophrenia. Neuropsychopharmacology. 1999;20:131–140
  16. Choe BY, Suh TS, Shinn KS, Lee CW, Lee C, Paik IH. Observation of metabolic changes in chronic schizophrenia after neuroleptic treatment by in vivo hydrogen magnetic resonance spectroscopy. Investigative Radiology. 1996;31:345–352
  17. Corson W, O'Leary DS, Miller D, Andreasen NC. The effects of neuroleptic medications on basal ganglia blood flow in schizophreniform disorders: a comparison between the neuroleptic-naive and medicated states. Biological Psychiatry. 2002;52:855–862
  18. Critchlow HM, Maycox PR, Skepper JN, Krylova O. Clozapine and haloperidol differentially regulate dendritic spine formation and synaptogenesis in rat hippocampal neurons. Molecular and Cellular Neuroscience. 2006;32:356–365
  19. Davis CE, Jeste DV, Eyler LT. Review of longitudinal neuroimaging studies of drug treatments in patients with schizophrenia. Schizophrenia Research. 2005;78:45–60
  20. Friedman L, Knutson L, Shurell M, Meltzer HY. Prefrontal sulcal prominence is inversely related to response to clozapine in schizophrenia. Biological Psychiatry. 1991;29:865–877
  21. Grasby PM, Friston KJ, Bench CJ, Cowen PJ, Frith CD, Liddle PF, et al. The effect of the dopamine agonist, apomorphine, on regional cerebral blood flow in normal volunteers. Psychological Medicine. 1993;23:605–612
  22. Heaton RK. Wisconsin Card Sorting Test Manual. Odessa, Fla: Psychological Assessment Resources; 1981;
  23. Heimberg C, Komoroski RA, Lawson WB, Cardwell D, Karson CN. Regional proton magnetic resonance spectroscopy in schizophrenia and exploration of drug effect. Psychiatry Research. 1998;83:105–115
  24. Holcomb HH, Cascella NG, Thaker GK, Medoff DR, Dannals RF, Tamminga CA. Functional sites of neuroleptic drug action in the human brain: PET/FDG studies with and without haloperidol. American Journal of Psychiatry. 1996;153:41–49
  25. Kay SR, Fiszbern A, Opler LA. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophrenia Bulletin. 1987;13:261–276
  26. Kapur S, Meyer J, Wilson AA, Houle S, Brown GM. Activation of specific cortical regions by apomorphine: an [15O] H2O PET study in humans. Neuroscience Letters. 1994;176:21–24
  27. Kapur S, Seeman P. Does fast dissociation from the D2 receptor explain the action of atypical antipsychotics? A new hypothesis. American Journal of Psychiatry. 2001;158:360–369
  28. Lahti A, Holcomb HH, Weiler MA, Medoff DR, Tamminga CA. Functional effects of antipsychotic drugs: comparing clozapine with haloperidol. Biological Psychiatry. 2003;53:601–608
  29. Lahti AC, Holcomb HH, Weiler MA, Medoff DR, Frey KN, Hardin M, et al. Clozapine but not haloperidol re-establishes normal task activated rCBF patterns in schizophrenia within the anterior cingulate cortex. Neuropsychopharmacology. 2004;1:171–178
  30. Lancaster JL, Woldorff MG, Parsons LM, Liotti M, Freitas CS, Rainey L, et al. Automated Talairach Atlas labels for functional brain mapping. Human Brain Mapping. 2000;10:120–131
  31. Leucht S, Kane JM, Etschel E, Kissling W, Hamann J, Engel RR. What does the PANSS mean?. Schizophrenia Research. 2005;79:231–238
  32. Lezak MD. Neuropsychological Assessment. 3rd edition. New York: Oxford University Press; 1995;
  33. Li Z, Huang M, Ichikawa J, Meltzer HY. N-Desmethylclozapine, a major metabolite of clozapine, increases cortical acetylcholine and dopamine release in vivo via stimulation of M1 muscarinic receptors. Neuropsychopharmacology. 2005;30:1986–1995
  34. Lu ZH, Chakraborty G, Ledeen RW, Yahya D, Wu G. N-acetylaspartate synthase is bimodally expressed in microsomes and mitochondria of brain. Brain Research Molecular Brain Research. 2004;122:71–78
  35. Machado AMC. Multiple testing correction in medical image analysis. Journal of Mathematical Imaging and Vision. 2007;29:107–117
  36. Meltzer HY, McGurk SR. The effects of clozapine, risperidone and olanzapine on cognitive function in schizophrenia. Schizophrenia Bulletin. 1999;25:233–255
  37. Meltzer HY, Sumiyoshi T. Atypical antipsychotic drugs improve cognition in schizophrenia. Biological Psychiatry. 2003;53:265–267
  38. Miller BL. A review of chemical issues in 1H NMR spectroscopy. N-acetyl-L-aspartate, creatine and choline. NMR in Biomedicine. 1991;4:47–52
  39. Miller DD, Andreasen NC, O ' Leary DS, Watkins GL, Boles Ponto LL, Hichwa RD. Comparison of the effects of risperidone and haloperidol on regional cerebral blood flow in schizophrenia. Biological Psychiatry. 2001;49:704–715
  40. Molina Rodríguez V, Andrée RM, Castejón MJ, Capdevila Garcia E, Carreras Delgado JL, Vila FJ. SPECT study of regional cerebral perfusion in neuroleptic-resistant schizophrenic patients who responded or did not respond to clozapine. American Journal of Psychiatry. 1996;153:1343–1346
  41. Molina Rodriguez, V., Andrée, R.M., Castejon, M.J., Zamora, M.L., Alvaro, P.C., Delgado, J.L., Vila, F.J., 1997. Fronto-striatothalamic perfusion and clozapine response in treatment-refractory schizophrenic patients. Psychiatry Research: Neuroimaging 76, 51–61.
  42. Molina V, Reig S, Sarramea F, Sanz J, Francisco Artaloytia J, Luque R, et al. Anatomical and functional brain variables associated with clozapine response in treatment-resistant schizophrenia. Psychiatry Research: Neuroimaging. 2003;124:153–161
  43. Molina V, Gispert JD, Reig S, Sanz J, Pascau J, Santos A, et al. Cerebral metabolic changes induced by clozapine in schizophrenia and related to clinical improvement. Psychopharmacology. 2005;178:17–26
  44. Molina V, Sanz J, Sarramea F, Palomo T. Marked hypofrontality in clozapine-responsive patients. Pharmacopsychiatry. 2007;40:157–162
  45. Molina V, Tamayo P, Montes C, De Luxan A, Martin C, Rivas N, et al. Clozapine may partially compensate for task-related brain perfusion abnormalities in risperidone-resistant schizophrenia patients. Progress in Neuro-Psyhopharmacology and Biological Psychiatry. 2008;32:948–954
  46. Petroff OA. Biological 1H NMR spectroscopy. Comparative Biochemistry and Physiology. B. 1988;90:249–260
  47. Peuskens J, Demily C, Thibaut F. Treatment of cognitive dysfunction in schizophrenia. Clinical Therapeutics. 2005;27:25–37
  48. Sigmundsson T, Maier M, Toone BK, Williams SCR, Simmons A, Greenwood K, et al. Frontal lobe N-acetylaspartate correlates with psychopathology in schizophrenia: a proton magnetic resonance spectroscopy study. Schizophrenia Research. 2003;64:63–71
  49. Signoretti S, Marmarou A, Tavazzi B, Lazzarino G, Beaumont A, Vagnozz R. N-acetylaspartate reduction as a measure of injury severity and mitochondrial dysfunction following diffuse traumatic brain injury. Journal of Neurotrauma. 2001;18:977–991
  50. Steen RG, Hamer RM, Lieberman JA. Measurement of brain metabolites by 1H magnetic resonance spectroscopy in patients with schizophrenia: a systematic review and meta-analysis. Neuropsychopharmacology. 2005;30:1949–1962
  51. Szulc A, Galinska B, Tarasow E, Kubas B, Dzienis W, Konarzewska B, et al. N-acetyl aspartate levels in selected areas of the brain in patients with chronic schizophrenia treated with typical and atypical neuroleptics: a proton magnetic resonance spectroscopy (1H MRS) study. Medical Science Monitor. 2007;13/s1:17–22
  52. Talairach J, Tournoux P. Atlas of Stereotaxic Anatomical Correlations of Gray and White Matter. New York: Thieme; 1993;
  53. Tanaka Y, Obata T, Sassa T, Yoshitome E, Asai Y, Ikehira H, et al. Quantitative magnetic resonance spectroscopy of schizophrenia: relationship between decreased N-acetyl aspartate and frontal lobe function. Psychiatry and Clinical Neurosciences. 2006;60:365–372
  54. Vaiva G, Thomas P, Llorca PM, Dupont S, Cottencin O, Devos P, et al. SPECT imaging, clinical features, and cognition before and after low doses of amisulpiride in schizophrenic patients with the deficit syndrome. Psychiatry Research: Neuroimaging. 2002;115:37–48
  55. Volkow ND, Wang GJ, Fowler JS, Logan J, Angrist B, Hitzemann R, et al. Effects of methylphenidate on regional brain glucose metabolism in humans: relationship to dopamine D2 receptors. American Journal of Psychiatry. 1997;154:50–55
  56. Wakade CG, Mahadik SP, Waller JL, Chiu FC. Atypical neuroleptics stimulate neurogenesis in adult rat brain. Journal of Neuroscience Research. 2002;69:72–79
  57. Wechsler D. Wechsler Memory Scale — Revised. New York: The Psychological Corporation; 1987;
  58. Weinberger, D.R., Berman, K.F., Zec, R.F., 1986. Physiologic dysfunction of dorsolateral prefrontal cortex in schizophrenia. I. regional cerebral blood flow evidence. Archives of General Psychiatry 43, 114–124.

PII: S0925-4927(09)00107-3

doi: 10.1016/j.pscychresns.2009.04.007

Psychiatry Research: Neuroimaging
Volume 174, Issue 2 , Pages 121-129 , 30 November 2009

Article Tools

* Image Usage & Resolution